A Comparative Review of Neutrophil Extracellular Traps in Sepsis

Abstract

Sepsis is the leading cause of critical illness and mortality in human beings and animals. Neutrophils are the primary effector cells of innate immunity during sepsis. Besides degranulation and phagocytosis, neutrophils also release neutrophil extracellular traps (NETs), composed of cell-free DNA, histones, and antimicrobial proteins. Although NETs have protective roles in the initial stages of sepsis, excessive NET formation has been found to induce thrombosis and multiple organ failure in murine sepsis models. Since the discovery of NETs nearly a decade ago, many investigators have identified NETs in various species. However, many questions remain regarding the exact mechanisms and fate of neutrophils following NET formation. In humans and mice, platelet-neutrophil interactions via direct binding or soluble mediators seem to play an important role in mediating NET formation during sepsis. Preliminary data suggest that these interactions may be species dependent. Regardless of these differences, there is increasing evidence in human and veterinary medicine suggesting that NETs play a crucial role in the pathogenesis of intravascular thrombosis and multiple organ failure in sepsis. Because the outcome of sepsis is highly dependent on early recognition and intervention, detection of NETs or NET components can aid in the diagnosis of sepsis in humans and veterinary species. In addition, the use of novel therapies such as deoxyribonuclease and non-anticoagulant heparin to target NET components shows promising results in murine septic models. Much work is needed in translating these NET-targeting therapies to clinical practice.

Introduction

Despite recent advances in medicine, sepsis remains one of the leading causes of death in critically ill people and animals (1–3). Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection (4). Multiple organ dysfunction, associated with increased mortality and morbidity, is a common manifestation of sepsis (1, 5). Factors such as virulence of the invading organisms, co-morbidities, and the host immunocompetence dictate the progression and outcome of sepsis (3, 6, 7).

Neutrophils are short-lived granulocytes that play a pivotal role in the initial defense against invading pathogens in mammals. Neutrophils, recruited to the site of infection, effectively kill microorganisms by phagocytosis, degranulation, and generation of reactive oxygen species (ROS) (8). In certain conditions, neutrophils enhance their antimicrobial properties by releasing neutrophil extracellular traps (NETs), composed of extracellular chromatin decorated with histones and numerous granular proteins (9). Many of these granular components like myeloperoxidase (MPO), α-defensins, elastase (NE), cathepin G, and lactoferrin, have bactericidal activities capable of eliminating microorganisms and/or their virulence factors. Uncontrolled inflammatory response during sepsis is the proposed underlying cause of excessive NET formation (10, 11). Increasing experimental and clinical evidence indicates that overzealous NET formation during sepsis can lead to the development of multiple organ dysfunction highlighting the pathophysiological role of NETs in sepsis (12–15). This review aims to summarize the recent knowledge on the underlying mechanisms of NET formation in varied species, as well as, the beneficial and detrimental effects of NETs found in various septic animal models.

Mechanism of NETosis

As sentinel cells of innate immunity, neutrophils can respond to many pathogens or their associated molecular patterns by releasing NETs. “NETosis” is the term commonly used to describe the sequence of cellular events leading up to the active release of NETs (9, 16). Similar to other forms of cell death such as apoptosis or programmed cell death and necroptosis, a regulated form of necrosis, NETosis is a highly regulated process. Dysregulation of NETosis found in many disease states like sepsis, can result in collateral damage to the host. The cellular mechanisms mediating the release of NETs, however, remain poorly understood. Brinkmann et al. and Fuchs et al. first documented in vitro NETosis in human neutrophils using the potent protein kinase C activator, phorbal 12-myristate 13-acetate (PMA) (17, 18). Following PMA stimulation, human neutrophils undergo morphological changes including chromatin decondensation, loss of nuclear envelope, mixing of nuclear contents and cytoplasmic granular proteins, loss of membrane integrity and, ultimately, release of cell free DNA (cfDNA) (18). A recent ex vivo study by the authors documented similar morphological changes in PMA-activated canine neutrophils indicating that dog neutrophils may undergo suicidal NETosis (19). Cell death is inevitable in neutrophils undergoing suicidal NETosis as they are unable to maintain a constant intracellular environment without an intact cell membrane. For that reason, some investigators describe this type of NETosis as “lytic” or “suicidal” (16). Table 1 is a summary of microorganisms known to induce NETosis in various species.

The generation of reactive oxygen species (ROS) by NAPDH oxidase is an integral, but not essential, cellular process in NETosis. Suicidal NETosis induced by PMA and pathogens such as Aspergillus fumigatus and Toxoplasma gondii are dependent on ROS generation, which occurs upstream of p38 mitogen-activated protein kinase (MAPK) and extracellular signal regulated kinase (ERK) phosphorylation (45, 46) (Figure 2). Interestingly, although PMA-activated neutrophils in horses undergo ROS generation, PMA is considered a weak trigger of ex vivo NETosis, suggesting that the role of ROS in NETosis may vary among species (24, 47) (Figure 1A). It is not yet clear how ROS generation and its downstream effects ultimately lead to chromatin decondensation and the release of cfDNA. Papyannopoulos et al. found that the translocation of both neutrophil elastase (NE) and myeloperoxidase granules from the cytoplasm to the nucleus is essential for chromatin decondensation during PMA-mediated NETosis. This process appears to be independent of the enzymatic activities of NE but the exact molecular mechanism responsible for this translocation is unclear (48).

Figure 1

Figure 2

Many critics question the physiological relevance of PMA-mediated NETosis (49, 50). First, NETosis induced by PMA in vitro requires hours to occur, whereas neutrophils in vivo normally undergo phagocytosis and degranulation within minutes after encountering microorganisms. Second, some investigators consider PMA-induced NETosis “suicidal,” given that PMA-activated neutrophils can no longer maintain normal cell function following NETosis. To better understand the relevance of NETosis in vivo, Yipp et al. directly visualized the behaviors of neutrophils within Staphylococcus aureus (S. aureus) skin infections in mice and human beings using intravital microscopy. They found that neutrophils undergo chromatin decondensation and DNA release within minutes after encountering S. aureus while maintaining an intact cell membrane. Interestingly, the NETosing neutrophils, now anuclear, continued to chemotax to and phagocytize nearby bacteria (20). This unique mechanism of NETosis, termed “vital” NETosis, was later confirmed in septic murine models using either lipopolysaccharides (LPS) or E. coli. Besides maintaining their functional capacity following vital NETosis, neutrophils must somehow release their DNA while preserving the integrity of the cell membrane. The Kubes laboratory answered this question by demonstrating that in the presence of S. aureus human neutrophils form budding DNA-containing vesicles from the nuclear envelop, which later, fuse with the plasma membrane to release DNA to the extracellular space (22) (Figure 2). In horses, ex vivo exposure of neutrophils to endometritis causing bacteria, also results in rapid NET formation but the viability and functional capacity of those neutrophils remain unknown (24). To date, how neutrophils commit to one form of NETosis over the other remains unclear, but some investigators believe that it may be stimulus-dependent (11, 16).

Studies in murine, human, and canine neutrophils demonstrated that NETosis and the release of histones and DNA require histone post-translational modification (30, 51, 52). Histone citrullination, catalyzed by the enzyme, peptidylarginine deiminase 4 (PAD4), results in a net loss of positive charge of histones. This, in turn, obliterates electrostatic interactions between DNA and histones causing chromatin decondensation and release of cfDNA during NETosis (53–55). Induction of PAD4 activation in neutrophils appears to be stimuli dependent. The proinflammatory cytokine, Tumor Necrosis Factor-α, hydrogen peroxide and molecular patterns like LPS and lipoteichoic acid have been shown to induce PAD4 activation and histone citrullination (19, 30, 32, 55). The elevation of citrullinated histones in clinical septic patients suggest that ongoing activation of PAD4 occurs during sepsis.

NETosis and platelet-neutrophil interaction

In addition to being the primary effector cells of hemostasis, recent evidence indicates that murine, human and canine platelets play a direct role in innate immunity by directly interacting with pathogens or recognizing pathogen-associated molecular patterns (PAMPs). Platelets also augment innate immunity by facilitating NETosis via platelet-neutrophil interaction (26). In ex vivo systems, human, murine, and canine neutrophils undergo a limited degree of NETosis in response to LPS (19, 31, 56). But in the presence of LPS-activated platelets, murine and human neutrophils release substantial amounts of NETs, indicating that sepsis-associated NETosis is highly dependent on platelet-neutrophil interaction. Clark et al. first discovered that platelet-mediated NETosis induced by LPS in humans is dependent on platelet Toll-like receptor 4 (TLR4) (26). Subsequent studies in mouse sepsis models showed that intravascular NETosis under shear conditions is highly dependent on platelet-neutrophil interaction. McDonald et al. found that LPS-treated mice not only had increased platelet-neutrophil aggregates but also NETs within their liver sinusoids. However, this process does not occur in platelet-depleted mice treated with the same doses of LPS (27). In addition to LPS, platelets activated by the agonists, thrombin, ADP, and arachidonic acid also stimulate NETosis in humans and mice (57). The exact mechanism of platelet-mediated NETosis, however, is not clearly understood and, likely, differs among species.

In general, platelet-neutrophil interactions can be broadly divided into 2 mechanisms: adhesive and soluble. Regardless of the mechanisms involved, platelet activation induced by pathogens, damage-associated molecular patterns, or classic agonists must occur in order for secretion of soluble mediators and expression/activation of adhesion molecules to occur. Platelet activation by stimulants results in inside-out signaling that leads to the expression of P-selectin and a conformational change in the extracellular domains of the integrin, α_IIbβ₃, increasing its affinity for ligands. The binding of platelet P-selectin to its neutrophil receptor, P-selectin glycoprotein ligand-1 (PSGL-1) is shown to be essential in inducing NETosis in mice with sepsis and transfusion-induced acute lung injury (58, 59). However, treatment of activated human platelets with anti-P-selectin function blocking antibodies does not attenuate NETosis suggesting that P-selectin/PSGL-1-mediated NETosis may be species dependent (60, 61). In mice and humans, platelet-neutrophil interaction and NETosis also are mediated by the binding of α_Mβ₂ (MAC-1), a neutrophil integrin, to its counterreceptor, glycoprotein 1bα (GP1bα), a heterodimeric glycoprotein on platelets (62–64).

Upon activation, platelets secrete a variety of soluble mediators like high mobility group box-1 (HMBG-1) and platelet factor 4 (PF4), known to modulate NETosis. Platelet factor 4 or CXCL4 and CCL5 (RANTES), released by LPS-activated platelets, are platelet-derived chemokines that can activate neutrophils to undergo adhesion. In mice, thrombin-stimulated platelets release both CXCL4 and CCL5, which induce NETosis via the neutrophil G-protein coupled receptors. The heterodimerization of platelet-derived CXCL4 and CCL5 are found to enhance NETosis (64). LPS or the synthetic lipopeptide, Pam3CSK4, also stimulates platelets via TLR 4 or 2, respectively, to release CXCL4 enhancing NETosis in human neutrophils (61). Platelet-derived HMGB-1, a damage-associated molecular pattern, secreted by activated platelets, stimulates human and mouse neutrophils to undergo NETosis by binding to receptor for advanced glycation endproducts (RAGE). The role of HMGB1-RAGE signaling pathway in the formation of NETs is unclear but downstream pathways of RAGE have been shown to facilitate autophagy, an essential cellular event during NETosis (60, 65–67). Activated neutrophils also contribute to this cellular cross-talk by shuttling arachidonic acid containing extracellular vesicles to platelets, in which arachidonic acid is synthesized to thromboxane A₂ by cyclooxygenase-1 for further platelet activation (68). It is important to note that the adhesive and soluble interactions between platelets and neutrophils synergistically mediate NETosis since inhibition of either type of interaction inhibits NET formation. Table 2 summarizes the molecular interactions between neutrophils and platelets during NETosis.

Table 2

Stimulants	Platelet		Neutrophil	Species	Clinical relevance	References
ADHESIVE INTERACTIONS
Thrombin LPS	P-selectin ?	↔ ↔	PSGL-1 LFA-1 (CD11a)	Mice	Sepsis	(59) (27)
LPS	?	↔	LFA-1 (CD11a)	Humans	Sepsis	(27)
TRAP	GP1bα	↔	MAC-1 (αMβ2)	Mice	Acute Lung Injury	(64)
LPS Pam3CSK4 Arachidonic acid	GP1bα	↔	Beta-2 integrin	Humans	Sepsis	(61)
SOLUBLE INTERACTIONS
LPS	TxA2		?	Mice	Transfusion-related acute lung injury	(57)
Collagen Thrombin ADP	HMGB1		RAGE	Mice Humans	Coronary thrombosis	(60)
TRAP	Platelet Factor 4 (CXCL4) /CCL5 (RANTES) heterodimer		?	Mice	Acute Lung Injury	(64)
LPS Pam3CSK4 arachidonic acid	Platelet Factor 4 (CXCL4)		?	Humans	Sepsis	(61)
ADP, fMLP	MAC-1		Vesicles containing arachidonic acid	Mice	Sepsis associated acute Lung Injury	(68)
Citrullinated histones	TLR2 TLR4		NETs		?	(69)

Summary of NETosis mediated by platelet-neutrophil interactions.

PSGL-1, P-selectin glycoprotein ligand-1; LFA-1, lymphocyte function-associated antigen 1; LPS, Lipopolysaccharide; MAC-1, Macrophage-1 antigen; GP1ba, Glycoprotein 1b alpha; TxA₂, Thromboxane A₂; HMBG1, High Mobility Group Box 1; RAGE, Advanced Glycation Endproducts; TRAP, Thrombin receptor-activating peptide; Fmlp, N-Formylmethionin-leukcyl-phenylalanine, ?; Unknown.

Beneficial role of NETs in sepsis

Microbial trapping and prevention of dissemination

In a mouse model of necrotizing fasciitis, PAD4 knockout mice with the decreased ability to produce NETs were more susceptible to Staphylococcus (S.) aureus infection strongly suggesting that NETs have protective roles in the defense against invading organisms (21). NETs have been shown to exert antimicrobial activities by physically trapping or directly killing microorganisms. The earliest evidence of the antimicrobial properties of NETs was gathered using high-definition scanning electron microscopy. Microorganisms including: Shigella flexneri, S. aureus, Klebsiella pneumoniae, Candida albicans, and Leishmania were observed to be physically attached onto the structural elements of NETs. The ability of NETs to trap bacteria was confirmed by Buchanan et al., who utilized group A Streptococcus that expresses deoxyribonuclease (DNase), in a mouse model of necrotizing fasciitis. The group found that mice treated with the strain that expresses DNase had more substantial skin lesions and bacterial dissemination indicating that NETs not only enhance the killing of bacteria but also ensnare bacteria to hinder their spread (70). This was further confirmed by McDonald et al. who utilized fluorescently labeled E. coli to document in vivo trapping of bacteria within the liver sinusoids in LPS-treated mice (27). The group also found that NETs within the liver sinusoids potentiate the ability of the liver to entrap bacteria once the Kupffer cells are overwhelmed by extensive bacteremia. As expected, microorganisms that possess the ability to rapidly breakdown DNA are more virulent. For example, Streptococcus pneumoniae, a Gram-positive bacteria commonly found in the human respiratory tract, can express the virulence factor, endA, which degrades DNA, allowing for bacteremia and sepsis to occur (71). We recently demonstrated that NETs within the septic foci of clinical septic dogs can bind directly to bacteria suggesting that entrapment of bacteria by NETs may occur in dogs (Figures 1B,C) (72).

Direct antimicrobial activity

In theory, NETs should possess antimicrobial properties since NET components like histones, cathepsin G, and MPO can exert bactericidal activities. However, the direct antimicrobial activity of NETs in vivo is controversial. The conflicting published data likely reflects the different methods used to measure the antimicrobial properties of NETs (73). The most direct way of evaluating the microcidal properties of NETs in vitro is by culturing microbes and assessing their viability after incubation with NET-forming neutrophils. Using this method, studies found that NETs dismantled by DNase digestion allowed for the growth of entrapped S. aureus and Candida albicans (74). One plausible explanation for this, is that granular proteases released into the extracellular space are rapidly inactivated by plasma alpha1-proteinase inhibitor. Proteases like NE must, therefore, be shielded from nucleic acids in order to carry out its proteolytic and microcidal activities. Another method used by investigators is to assess the viability of microbes in the presence of neutrophils that are unable to produce NETs. By using neutrophils from human patients with chronic granulomatous disease, a familial disease caused by mutations of the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase gene, Bianchi et al. showed that the lack of NETosis was associated with growth of Aspergillus nidulans (42). Since PAD4 is required for NETosis, Li et al. found that neutrophils from PAD4 knockout mice had limited abilities to kill Shigella flexneri when phagocytosis was inhibited demonstrating that killing of Shigella flexneri is mediated by NETs (21). NET components also can minimize the pathogenicity of microbes by inactivating their virulence factors. For example, NE found within NETs inactivates the virulence factors IpaB and Ipac A in S. flexneri making the invasion into the colonic mucosa and escape from phagocytic vacuoles more difficult (17, 75).

Detrimental role of NETs in sepsis

While NETs protect the host by limiting microbial growth and dissemination, excessive NETosis during sepsis can be detrimental to the host. Recent discoveries in in vitro experiments and animal models demonstrated the crucial role of NETs in the pathogenesis of intravascular thrombosis, disseminated intravascular coagulation (DIC), and multiple organ dysfunction, all of which can increase morbidity and mortality in sepsis (1, 5).

NETs and thrombosis in sepsis

Systemic inflammation and release of proinflammatory cytokines during sepsis can result in abnormal activation of the coagulation system. Excessive thrombosis is normally prevented by concurrent activation of the anticoagulant pathways involving tissue factor pathway inhibitor, antithrombin, thrombomodulin, and protein C. Ongoing activation of the coagulation pathways during sepsis can overwhelm the anticoagulant systems leading to excessive intravascular thrombosis. Ultimately, overconsumption of platelets and coagulation proteins result in consumptive coagulopathy or DIC. Advanced DIC in septic patients usually presents as hemorrhage or multiple organ failure. Recent evidence in humans and dogs demonstrates that NETs and their components can exacerbate DIC by directly enhancing ex vivo clot formation, activating platelets, as well as, inhibiting anticoagulant pathways (76–78). Observational studies have shown that human or canine septic patients have aberrant amounts of circulating cell-free DNA (cfDNA), which can influence the dynamics of thrombus formation in several ways (12, 79). Studies in human patients found that cfDNA concentration in plasma from septic humans correlates positively with the rate and extent of thrombin generation (76). Oligonucleotides of double-stranded DNA-hairpins can bind to both factor XII and high molecular weight kininogen (HMWK) thus accelerating the activation of factor XII and prekallikrein, both critical in initiating the contact pathway of coagulation (80, 81). cfDNA not only impairs fibrinolysis by inhibiting tissue plasminogen activator, it also fortifies thrombus ultrastructure by creating a scaffold for the binding of red blood cells, platelets, fibrin and coagulation factors (82). Besides cfDNA, other NET components also exert procoagulant properties. Extracellular histones can induce platelet activation, platelet aggregation, and thrombin generation via platelet TLR2 and TLR4 (69). Extracellular histones also dose-dependently inhibit the generation of activated protein C in the presence of thrombomodulin (83). Neutrophil elastase (NE) and cathepsin G can proteolytically degrade tissue factor pathway inhibitor bound on human endothelial cells in vitro (84). The pathophysiological relevance of NETs-induced thrombosis has been further explored in septic mouse models. Intravital imaging of organs of LPS-treated mice demonstrated entrapment of cfDNA within pulmonary capillaries and post-capillary venules where formation of platelet-leukocyte aggregates impedes blood flow in microvessels (85).

The role of NETs in sepsis associated multiple organ failure

Studies in human septic patients have shown that aberrant amounts of circulating NET components, including cfDNA and histones, are associated with poor outcome and multiple organ failure (86). cfDNA has a short half-life of 0–15 min in circulation due to enzymatic degradation by endogenous DNases and hepatic clearance. In sepsis, elevated levels of circulating cfDNA could be due to increased NETosis, apoptosis, necrosis or decreased clearance. Several in vivo studies in septic mouse models have shown improved survival and attenuation of organ injury by increasing cfDNA clearance using exogenous DNase (14, 15). The exact mechanisms of how cfDNA contributes to organ dysfunction are not clear. It is possible that degradation of cfDNA likely reduces the formation of microthrombi, and thereby, alleviating microvascular occlusion and tissue hypoxia. The immune modulatory effects of exogenous DNase seen in the septic mice also suggest that cfDNA may play a role in inflammation. Cell-free DNA from serum has been demonstrated to induce TNF-α mRNA expression in human monocytes and the telomeric sequence of cfDNA is potentially involved in the fine tuning of inflammation (87). Besides playing a key role in chromatin remodeling and gene transcription, histones, once released into the vascular space, can function as damage-associated molecular patterns. Extracellular histones can induce organ damage by functioning as a chemokine to promote proinflammatory cytokine release, induce apoptosis of leukocytes or nearby cells and incite direct cytotoxicity. Findings from in vitro studies of human endothelial cells suggest that extracellular histones may directly cause endothelial dysfunction by inducing cytotoxicity and increasing ROS to modulate nitric oxide production. Nitric oxide, generated by nitric oxide synthase, is important for maintaining vasodilation and normal tissue perfusion in health and disease (88, 89). Activation of endothelial cells further promote adhesion and transmigration of leukocytes to tissues. In mice, ischemic reperfusion injury can result in elevation of extracellular histones triggering the production of proinflammatory cytokines (90). in vivo histone injection into the renal arteries of mice induces acute kidney injury by directly causing renal tubular cell necrosis and expression of IL-6 and TNF-α via TLR2 and 4 (91).

Acute respiratory distress syndrome (ARDS) is characterized by disruption of the alveolar-capillary barrier resulting in increased permeability of the endothelial and epithelium leading to protein-rich edema and subsequent respiratory failure. Migration of neutrophils from the vasculature into the interstitium and bronchoalveolar space is a key feature of ARDS in sepsis. NETs in bronchoalveolar lavage fluid collected from septic people and dogs with ARDS have recently been documented indicating that transmigrated neutrophils undergo NETosis in naturally occurring ARDS (56, 57, 72, 92). Serine proteases released via NETosis can have a direct pathophysiological role in the progression of ARDS. For example, proteinase-3, cathepsin G and NE can degrade surfactant D and A, both of which are important in the clearance of inflammatory cells and attenuation of residual inflammation (93, 94). in vitro studies have shown that NE increases alveolar epithelial permeability by altering the actin cytoskeleton of epithelial cells (95). Extracellular histones released via NETosis also may exacerbate neutrophil accumulation migration and elicit direct destruction of the alveolar epithelium leading to disruption of the alveolar permeability barrier.

Potential therapeutic targets

Since the outcome in sepsis depends heavily on early recognition and interventions, clinical assessment of NETs may serve as a valuable biomarker for the early diagnosis of sepsis. Direct visualization and quantification of NETs using immunofluorescence microscopy in clinical samples can be challenging since this technique is labor intensive and requires advanced training in microscopy. Preliminary studies using flow cytometry and advanced sequencing to quantify surrogates of NETosis like cfDNA, histones and nucleosomes in serum or plasma have shown promising results as these methods are more objective, reliable and repeatable than microscopy(96). Because overzealous production of NETs causes organ dysfunction and mortality, therapeutic interventions that target NET production or individual NET components present novel treatment strategies for sepsis. As mentioned previously, elevated levels of cfDNA released from NETosing neutrophils can have detrimental effects by activating the coagulation system and inflammation. One study showed that delayed systemic treatment of recombinant DNase in a mouse sepsis model reduces organ damage and bacterial dissemination, while early administration (2 h after cecal ligation) yields the opposite effects suggesting that NET-targeted therapy may be time-dependent (14). Interestingly, findings from a different study showed that early and concurrent treatment with DNase and antibiotics resulted in improved survival, reduced bacteremia and organ dysfunction(15). This indicates that combined therapies that incorporate conventional treatments such fluid therapy, antibiotics and NET-targeted drugs can potentially optimize treatment efficacy and outcome in clinical septic patients. To the authors' knowledge, there are no clinical trials to date evaluating the use of systemic DNase in clinical sepsis.

Treatment of PAD4 is a suitable therapeutic target because of its essential role in sepsis-mediated NETosis. In a mouse model of lupus, systemic treatment with the PAD4 inhibitor, BB-Cl-amidine, protects mice from developing NET-mediated vascular damage, endothelial dysfunction and kidney injury (97, 98). Sepsis models utilizing PAD4 knockout mice demonstrated that PAD4 deficiency improves survival and decreases the severity of organ dysfunction without exacerbating bacteremia (99, 100). Nonetheless, since the long-term physiologic consequences of systemic PAD4 inhibition are unknown, developing a suitable targeted therapy for PAD4 can be challenging.

Given its proinflammatory, cytotoxic and prothrombotic properties, citrullinated histone H3 (citH3) is a potential molecular target in sepsis. By neutralizing circulating citH3 in a septic mouse model, Li et al. found that blockade of citH3 significantly improves survival (101). Non-anticoagulant heparin, which binds to extracellular histones with minimal affinity to antithrombin, has been shown to reduce histone-mediated cytotoxicity, attenuate endotoxin-mediated lung injury and improve survival in septic mice (102). Although citrullinated histones have been found in canine and equine NETs, further studies are needed to characterize their effects in these species (Figure 1) (30). Activated protein C, a natural anticoagulant, cleaves extracellular histones abolishing the ability of histones to induce ex vivo platelet activation and potentially its cytotoxic and proinflammatory properties (69). However, large-scale randomized clinical trials evaluating the efficacy of recombinant protein C for human septic patients did not demonstrate any clinical benefits of protein C, ultimately, leading to its withdrawal (103).

Because platelet activation and platelet-neutrophil interaction are crucial for NETosis to occur, antiplatelet therapy may attenuate NETosis and its detrimental effects in sepsis. Recent studies in human and canine platelets have shown that endotoxin-mediated platelet activation requires excessive production of eicosanoids like thromboxane A₂ (104, 105). In a mouse model of endotoxin-triggered acute lung injury, pretreatment of mice with acetylsalicylic acid or aspirin, which prevents thromboxane A₂ generation, decreases intravascular NET formation and the degree of lung injury (57). Inhibition of the platelet ADP receptor, P2Y12, may also attenuate platelet-neutrophil interaction and NETosis, as endotoxin-mediated platelet activation is dependent on ADP in canine and equine platelets (19). Interestingly, prehospital administration of antiplatelet therapy has been shown in several observational studies, to be associated with improved outcome in human clinical patients with sepsis(106, 107). A large-scale clinical trial evaluating the benefits of aspirin therapy in sepsis is currently underway (108).

Conclusion

Evidence in the literature indicates that NETosis is a highly conserved mechanism of innate immunity among numerous species. Research in mice and people demonstrates that the dysregulation of NETosis caused by sepsis can have detrimental effects resulting in inflammation, thrombosis and multiple organ failure. NETs may play a similar pathophysiological role in other species. NETosis and NET components are potential therapeutic targets for the treatment of sepsis.

References

• 1.

  KenneyEMRozanskiEARushJEDelaforcade-BuressAMBergJRSilversteinDCet al. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc. (2010) 236:83–7. 10.2460/javma.236.1.83

  • CrossRef
  • Google Scholar

• 2.

  LevyMMRhodesAPhillipsGSTownsendSRSchorrCABealeRet al. Surviving sepsis campaign: association between performance metrics and outcomes in a 7.5-year study. Crit Care Med. (2015) 43:3–12. 10.1097/CCM.0000000000000723

  • CrossRef
  • Google Scholar

• 3.

  BabyakJMSharpCR. Epidemiology of systemic inflammatory response syndrome and sepsis in cats hospitalized in a veterinary teaching hospital. J Am Vet Med Assoc. (2016) 249:65–71. 10.2460/javma.249.1.65

  • CrossRef
  • Google Scholar

• 4.

  SingerMDeutschmanCSSeymourCWShankar-HariMAnnaneDBauerMet al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). J Am Med Assoc. (2016) 315:801–10. 10.1001/jama.2016.0287

  • CrossRef
  • Google Scholar

• 5.

  VincentJLMorenoRTakalaJWillattsSDeMendonca ABruiningHet al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. (1996) 22:707–10. 10.1007/BF01709751

  • CrossRef
  • Google Scholar

• 6.

  DeGaudio ARRinaldiSChelazziCBorracciT. Pathophysiology of sepsis in the elderly: clinical impact and therapeutic considerations. Curr Drug Targets (2009) 10:60–70. 10.2174/138945009787122879

  • CrossRef
  • Google Scholar

• 7.

  ArteroAZaragozaRCamarenaJJSanchoSGonzalezRNogueiraJM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care (2010) 25:276–81. 10.1016/j.jcrc.2009.12.004

  • CrossRef
  • Google Scholar

• 8.

  NathanC. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. (2006) 6:173–82. 10.1038/nri1785

  • CrossRef
  • Google Scholar

• 9.

  BrinkmannVZychlinskyA. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol. (2007) 5:577–82. 10.1038/nrmicro1710

  • CrossRef
  • Google Scholar

• 10.

  KeshariRSJyotiADubeyMKothariNKohliMBograJet al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS ONE (2012) 7:e48111. 10.1371/journal.pone.0048111

  • CrossRef
  • Google Scholar

• 11.

  Delgado-RizoVMartinez-GuzmanMAIniguez-GutierrezLGarcia-OrozcoAAlvarado-NavarroAFafutis-MorrisM. Neutrophil extracellular traps and its implications in inflammation: an overview. Front Immunol. (2017) 8:81. 10.3389/fimmu.2017.00081

  • CrossRef
  • Google Scholar

• 12.

  DwivediDJToltlLJSwystunLLPogueJLiawKLWeitzJIet al. Prognostic utility and characterization of cell-free DNA in patients with severe sepsis. Crit Care (2012) 16:R151. 10.1186/cc11466

  • CrossRef
  • Google Scholar

• 13.

  KaplanMJRadicM. Neutrophil extracellular traps: double-edged swords of innate immunity. J Immunol. (2012) 189:2689–95. 10.4049/jimmunol.1201719

  • CrossRef
  • Google Scholar

• 14.

  MaiSHKhanMDwivediDJRossCAZhouJGouldTJet al. Delayed but not early treatment with DNase reduces organ damage and improves outcome in a murine model of sepsis. Shock (2015) 44:166–72. 10.1097/SHK.0000000000000396

  • CrossRef
  • Google Scholar

• 15.

  CzaikoskiPGMotaJMNascimentoDCSonegoFCastanheiraFVMeloPHet al. Neutrophil extracellular traps induce organ damage during experimental and clinical sepsis. PLoS ONE (2016) 11:e0148142. 10.1371/journal.pone.0148142

  • CrossRef
  • Google Scholar

• 16.

  YippBGKubesP. NETosis: how vital is it?Blood (2013) 122:2784–94. 10.1182/blood-2013-04-457671

  • CrossRef
  • Google Scholar

• 17.

  BrinkmannVReichardUGoosmannCFaulerBUhlemannYWeissDSet al. Neutrophil extracellular traps kill bacteria. Science (2004) 303:1532–5. 10.1126/science.1092385

  • CrossRef
  • Google Scholar

• 18.

  FuchsTAAbedUGoosmannCHurwitzRSchulzeIWahnVet al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. (2007) 176:231–41. 10.1083/jcb.200606027

  • CrossRef
  • Google Scholar

• 19.

  LiRHLNgGTablinF. Lipopolysaccharide-induced neutrophil extracellular trap formation in canine neutrophils is dependent on histone H3 citrullination by peptidylarginine deiminase. Vet Immunol Immunopathol. (2017) 193–194:29–37. 10.1016/j.vetimm.2017.10.002

  • CrossRef
  • Google Scholar

• 20.

  YippBGPetriBSalinaDJenneCNScottBNZbytnuikLDet al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med. (2012) 18:1386–93. 10.1038/nm.2847

  • CrossRef
  • Google Scholar

• 21.

  LiPLiMLindbergMRKennettMJXiongNWangY. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med. (2010) 207:1853–62. 10.1084/jem.20100239

  • CrossRef
  • Google Scholar

• 22.

  PilsczekFHSalinaDPoonKKFaheyCYippBGSibleyCDet al. A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J Immunol. (2010) 185:7413–25. 10.4049/jimmunol.1000675

  • CrossRef
  • Google Scholar

• 23.

  LippolisJDReinhardtTAGoffJPHorstRL. Neutrophil extracellular trap formation by bovine neutrophils is not inhibited by milk. Vet Immunol Immunopathol. (2006) 113:248–55. 10.1016/j.vetimm.2006.05.004

  • CrossRef
  • Google Scholar

• 24.

  RebordaoMRCarneiroCAlexandre-PiresGBritoPPereiraCNunesTet al. Neutrophil extracellular traps formation by bacteria causing endometritis in the mare. J Reprod Immunol. (2014) 106:41–9. 10.1016/j.jri.2014.08.003

  • CrossRef
  • Google Scholar

• 25.

  MoriYYamaguchiMTeraoYHamadaSOoshimaTKawabataS. Alpha-Enolase of Streptococcus pneumoniae induces formation of neutrophil extracellular traps. J Biol Chem. (2012) 287:10472–81. 10.1074/jbc.M111.280321

  • CrossRef
  • Google Scholar

• 26.

  ClarkSRMaACTavenerSAMcDonaldBGoodarziZKellyMMet al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med. (2007) 13:463–9. 10.1038/nm1565

  • CrossRef
  • Google Scholar

• 27.

  McDonaldBUrrutiaRYippBGJenneCNKubesP. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe. (2012) 12:324–33. 10.1016/j.chom.2012.06.011

  • CrossRef
  • Google Scholar

• 28.

  GrinbergNElazarSRosenshineIShpigelNY. Beta-hydroxybutyrate abrogates formation of bovine neutrophil extracellular traps and bactericidal activity against mammary pathogenic Escherichia coli. Infect Immun. (2008) 76:2802–7. 10.1128/IAI.00051-08

  • CrossRef
  • Google Scholar

• 29.

  WardiniABGuimaraes-CostaABNascimentoMTNadaesNRDanelliMGMazurCet al. Characterization of neutrophil extracellular traps in cats naturally infected with feline leukemia virus. J Gen Virol. (2010) 91:259–64. 10.1099/vir.0.014613-0

  • CrossRef
  • Google Scholar

• 30.

  LiRHLNgGTablinF. Lipopolysaccharide-induced neutrophil extracellular trap formation in canine neutrophils is dependent on histone H3 citrullination by peptidylarginine deiminase. Vet Immunol Immunopathol. (2017) 193–194:29–37.

  • Google Scholar

• 31.

  PieterseERotherNYanginlarCHilbrandsLBVanDer Vlag J. Neutrophils discriminate between lipopolysaccharides of different bacterial sources and selectively release neutrophil extracellular traps. Front Immunol. (2016) 7:484. 10.3389/fimmu.2016.00484

  • CrossRef
  • Google Scholar

• 32.

  NeeliIKhanSNRadicM. Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. (2008) 180:1895–902. 10.4049/jimmunol.180.3.1895

  • CrossRef
  • Google Scholar

• 33.

  ScharrigECarestiaAFerrerMFCedolaMPretreGDrutRet al. Neutrophil extracellular traps are involved in the innate immune response to infection with leptospira. PLoS Negl Trop Dis. (2015) 9:e0003927. 10.1371/journal.pntd.0003927

  • CrossRef
  • Google Scholar

• 34.

  HemmersSTeijaroJRArandjelovicSMowenKA. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE (2011) 6:e22043. 10.1371/journal.pone.0022043

  • CrossRef
  • Google Scholar

• 35.

  TripathiSVermaAKimEJWhiteMRHartshornKL. LL-37 modulates human neutrophil responses to influenza A virus. J Leukoc Biol. (2014) 96:931–8. 10.1189/jlb.4A1113-604RR

  • CrossRef
  • Google Scholar

• 36.

  Munoz-CaroTMenaHuertas SJConejerosIAlarconPHidalgoMABurgosRAet al. Eimeria bovis-triggered neutrophil extracellular trap formation is CD11b-, ERK 1/2-, p38 MAP kinase- and SOCE-dependent. Vet Res. (2015) 46:23. 10.1186/s13567-015-0155-6

  • CrossRef
  • Google Scholar

• 37.

  BehrendtJHRuizAZahnerHTaubertAHermosillaC. Neutrophil extracellular trap formation as innate immune reactions against the apicomplexan parasite Eimeria bovis. Vet Immunol Immunopathol. (2010) 133:1–8. 10.1016/j.vetimm.2009.06.012

  • CrossRef
  • Google Scholar

• 38.

  SilvaLMCaroTMGerstbergerRVila-VicosaMJCortesHCHermosillaCet al. The apicomplexan parasite Eimeria arloingi induces caprine neutrophil extracellular traps. Parasitol Res. (2014) 113:2797–807. 10.1007/s00436-014-3939-0

  • CrossRef
  • Google Scholar

• 39.

  Munoz-CaroTSilvaLMRitterCTaubertAHermosillaC. Besnoitia besnoiti tachyzoites induce monocyte extracellular trap formation. Parasitol Res. (2014) 113:4189–97. 10.1007/s00436-014-4094-3

  • CrossRef
  • Google Scholar

• 40.

  AbiAbdallah DSLinCBallCJKingMRDuhamelGEDenkersEY. Toxoplasma gondii triggers release of human and mouse neutrophil extracellular traps. Infect Immun. (2012) 80:768–77. 10.1128/IAI.05730-11

  • CrossRef
  • Google Scholar

• 41.

  ReichelMMunoz-CaroTSanchezContreras GRubioGarcia AMagdowskiGGartnerUet al. Harbour seal (Phoca vitulina) PMN and monocytes release extracellular traps to capture the apicomplexan parasite Toxoplasma gondii. Dev Comp Immunol. (2015) 50:106–15. 10.1016/j.dci.2015.02.002

  • CrossRef
  • Google Scholar

• 42.

  BianchiMHakkimABrinkmannVSilerUSegerRAZychlinskyAet al. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood (2009) 114:2619–22. 10.1182/blood-2009-05-221606

  • CrossRef
  • Google Scholar

• 43.

  BrunsSKniemeyerOHasenbergMAimaniandaVNietzscheSThywissenAet al. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog. (2010) 6:e1000873. 10.1371/journal.ppat.1000873

  • CrossRef
  • Google Scholar

• 44.

  ByrdASO'brienXMJohnsonCMLavigneLMReichnerJS. An extracellular matrix-based mechanism of rapid neutrophil extracellular trap formation in response to Candida albicans. J Immunol. (2013) 190:4136–48. 10.4049/jimmunol.1202671

  • CrossRef
  • Google Scholar

• 45.

  ItakuraAMcCartyOJ. Pivotal role for the mTOR pathway in the formation of neutrophil extracellular traps via regulation of autophagy. Am J Physiol Cell Physiol. (2013) 305:C348–354. 10.1152/ajpcell.00108.2013

  • CrossRef
  • Google Scholar

• 46.

  KeshariRSVermaABarthwalMKDikshitM. Reactive oxygen species-induced activation of ERK and p38 MAPK mediates PMA-induced NETs release from human neutrophils. J Cell Biochem. (2013) 114:532–40. 10.1002/jcb.24391

  • CrossRef
  • Google Scholar

• 47.

  CoteOClarkMEVielLLabbeGSeahSYKhanMAet al. Secretoglobin 1A1 and 1A1A differentially regulate neutrophil reactive oxygen species production, phagocytosis and extracellular trap formation. PLoS ONE (2014) 9:e96217. 10.1371/journal.pone.0096217

  • CrossRef
  • Google Scholar

• 48.

  PapayannopoulosVMetzlerKDHakkimAZychlinskyA. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol (2010) 191:677–91. 10.1083/jcb.201006052

  • CrossRef
  • Google Scholar

• 49.

  KonigMFAndradeF. A critical reappraisal of neutrophil extracellular traps and netosis mimics based on differential requirements for protein citrullination. Front Immunol. (2016) 7:461. 10.3389/fimmu.2016.00461

  • CrossRef
  • Google Scholar

• 50.

  YousefiSSimonHU. NETosis - does it really represent nature's “Suicide Bomber”?Front Immunol. (2016) 7:328. 10.3389/fimmu.2016.00328

  • CrossRef
  • Google Scholar

• 51.

  LiYLiuBFukudomeEYLuJChongWJinGet al. Identification of citrullinated histone H3 as a potential serum protein biomarker in a lethal model of lipopolysaccharide-induced shock. Surgery (2011) 150:442–51. 10.1016/j.surg.2011.07.003

  • CrossRef
  • Google Scholar

• 52.

  LewisHDLiddleJCooteJEAtkinsonSJBarkerMDBaxBDet al. Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation. Nat Chem Biol. (2015) 11:189–91. 10.1038/nchembio.1735

  • CrossRef
  • Google Scholar

• 53.

  WangYLiMStadlerSCorrellSLiPWangDet al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol. (2009) 184:205–13. 10.1083/jcb.200806072

  • CrossRef
  • Google Scholar

• 54.

  LeshnerMWangSLewisCZhengHChenXASantyLet al. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol. (2012) 3:307. 10.3389/fimmu.2012.00307

  • CrossRef
  • Google Scholar

• 55.

  RohrbachASSladeDJThompsonPRMowenKA. Activation of PAD4 in NET formation. Front Immunol (2012) 3:360. 10.3389/fimmu.2012.00360

  • CrossRef
  • Google Scholar

• 56.

  LiuSSuXPanPZhangLHuYTanHet al. Neutrophil extracellular traps are indirectly triggered by lipopolysaccharide and contribute to acute lung injury. Sci Rep. (2016) 6:37252. 10.1038/srep37252

  • CrossRef
  • Google Scholar

• 57.

  CaudrillierAKessenbrockKGillissBMNguyenJXMarquesMBMonestierMet al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. (2012) 122:2661–71. 10.1172/JCI61303

  • CrossRef
  • Google Scholar

• 58.

  SreeramkumarVAdroverJMBallesterosICuarteroMIRossaintJBilbaoIet al. Neutrophils scan for activated platelets to initiate inflammation. Science (2014) 346:1234–8. 10.1126/science.1256478

  • CrossRef
  • Google Scholar

• 59.

  EtulainJMartinodKWongSLCifuniSMSchattnerMWagnerDD. P-selectin promotes neutrophil extracellular trap formation in mice. Blood (2015) 126:242–6. 10.1182/blood-2015-01-624023

  • CrossRef
  • Google Scholar

• 60.

  MaugeriNCampanaLGavinaMCovinoCDeMetrio MPanciroliCet al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost. (2014) 12:2074–88. 10.1111/jth.12710

  • CrossRef
  • Google Scholar

• 61.

  CarestiaAKaufmanTRivadeneyraLLandoniVIPoznerRGNegrottoSet al. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol. (2016) 99:153–62. 10.1189/jlb.3A0415-161R

  • CrossRef
  • Google Scholar

• 62.

  DiacovoTGRothSJBuccolaJMBaintonDFSpringerTA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood (1996) 88:146–57.

  • Google Scholar

• 63.

  KonstantopoulosKNeelameghamSBurnsARHentzenEKansasGSSnappKRet al. Venous levels of shear support neutrophil-platelet adhesion and neutrophil aggregation in blood via P-selectin and beta2-integrin. Circulation (1998) 98:873–82. 10.1161/01.CIR.98.9.873

  • CrossRef
  • Google Scholar

• 64.

  RossaintJHerterJMVanAken HNapireiMDoringYWeberCet al. Synchronized integrin engagement and chemokine activation is crucial in neutrophil extracellular trap-mediated sterile inflammation. Blood (2014) 123:2573–84. 10.1182/blood-2013-07-516484

  • CrossRef
  • Google Scholar

• 65.

  DyerMRChenQWNealMDVogelS. HMGB1 expression on platelet-derived microparticles promotes deep vein thrombosis. J. Am College Surg. (2016) 223:S153. 10.1016/j.jamcollsurg.2016.06.331

  • CrossRef
  • Google Scholar

• 66.

  DyerMRChenQWHaldemanSYazdaniHHoffmanRLoughranPet al. Deep vein thrombosis in mice is regulated by platelet HMGB1 through release of neutrophil-extracellular traps and DNA. Sci Rep.8:206810.1038/s41598-018-20479-x

  • CrossRef
  • Google Scholar

• 67.

  ZhouHDengMHLiuYJYangCXHoffmanRZhouJJet al. Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice. Blood Adv. (2018) 2:638–48. 10.1182/bloodadvances.2017011817

  • CrossRef
  • Google Scholar

• 68.

  RossaintJKuhneKSkupskiJVanAken HLooneyMRHidalgoAet al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat. Commun. (2016) 7:13464. 10.1038/ncomms13464

  • CrossRef
  • Google Scholar

• 69.

  SemeraroFAmmolloCTMorrisseyJHDaleGLFriesePEsmonNLet al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood (2011) 118:1952–61. 10.1182/blood-2011-03-343061

  • CrossRef
  • Google Scholar

• 70.

  BuchananJTSimpsonAJAzizRKLiuGYKristianSAKotbMet al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol. (2006) 16:396–400. 10.1016/j.cub.2005.12.039

  • CrossRef
  • Google Scholar

• 71.

  BeiterKWarthaFAlbigerBNormarkSZychlinskyAHenriques-NormarkB. An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr Biol. (2006) 16:401–7. 10.1016/j.cub.2006.01.056

  • CrossRef
  • Google Scholar

• 72.

  LiRHLJohnsonLRKohenCTablinF. A novel approach to identifying and quantifying neutrophil extracellular trap formation in septic dogs using immunofluorescence microscopy. BMC Vet Res.14:210. 10.1186/s12917-018-1523-z

  • CrossRef
  • Google Scholar

• 73.

  BrinkmannVZychlinskyA. Neutrophil extracellular traps: is immunity the second function of chromatin?J Cell Biol. (2012) 198:773–83. 10.1083/jcb.201203170

  • CrossRef
  • Google Scholar

• 74.

  MenegazziRDeclevaEDriP. Killing by neutrophil extracellular traps: fact or folklore?Blood (2012) 119:1214–16. 10.1182/blood-2011-07-364604

  • CrossRef
  • Google Scholar

• 75.

  WeinrauchYDrujanDShapiroSDWeissJZychlinskyA.Neutrophil elastase targets virulence factors of enterobacteria. Nature (2002). 417:91–4. 10.1038/417091a

  • Pubmed Abstract
  • CrossRef
  • Google Scholar

• 76.

  GouldTJVuTTSwystunLLDwivediDJMaiSHWeitzJIet al. Neutrophil extracellular traps promote thrombin generation through platelet-dependent and platelet-independent mechanisms. Arterioscler Thromb Vasc Biol. (2014) 34:1977–84. 10.1161/ATVBAHA.114.304114

  • CrossRef
  • Google Scholar

• 77.

  GouldTJVuTTStaffordARDwivediDJKimPYFox-RobichaudAEet al. Cell-free DNA modulates clot structure and impairs fibrinolysis in sepsis. Arterioscler Thromb Vasc Biol. (2015) 35:2544–53. 10.1161/ATVBAHA.115.306035

  • CrossRef
  • Google Scholar

• 78.

  JefferyULevineDN. Canine neutrophil extracellular traps enhance clot formation and delay lysis. Vet Pathol. 55:116–23. 10.1177/0300985817699860

  • CrossRef
  • Google Scholar

• 79.

  LetendreJAGoggsR. Measurement of plasma cell-free DNA concentrations in dogs with sepsis, trauma, and neoplasia. J Vet Emerg Crit Care (2017) 27:307–14. 10.1111/vec.12592

  • CrossRef
  • Google Scholar

• 80.

  SchmaierAHMcCraeKR. The plasma kallikrein-kinin system: its evolution from contact activation. J Thromb Haemost. (2007) 5:2323–9. 10.1111/j.1538-7836.2007.02770.x

  • CrossRef
  • Google Scholar

• 81.

  GanslerJJaaxMLeitingSAppelBGreinacherAFischerSet al. Structural requirements for the procoagulant activity of nucleic acids. PLoS ONE (2012) 7:e50399. 10.1371/journal.pone.0050399

  • CrossRef
  • Google Scholar

• 82.

  MartinodKWagnerDD. Thrombosis: tangled up in NETs. Blood (2014) 123:2768–76. 10.1182/blood-2013-10-463646

  • CrossRef
  • Google Scholar

• 83.

  AmmolloCTSemeraroFXuJEsmonNLEsmonCT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost. (2011) 9:1795–803. 10.1111/j.1538-7836.2011.04422.x

  • CrossRef
  • Google Scholar

• 84.

  SteppichBASeitzIBuschGSteinAOttI. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Thromb Haemost. (2008) 100:1068–75. 10.1160/TH08-05-0293

  • CrossRef
  • Google Scholar

• 85.

  TanakaKKoikeYShimuraTOkigamiMIdeSToiyamaYet al. in vivo characterization of neutrophil extracellular traps in various organs of a murine sepsis model. PLoS ONE9:e11188810.1371/journal.pone.0111888

  • CrossRef
  • Google Scholar

• 86.

  HiroseTHamaguchiSMatsumotoNIrisawaTSekiMTasakiOet al. Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients. PLoS ONE (2014) 9:e111755. 10.1371/journal.pone.0111755

  • CrossRef
  • Google Scholar

• 87.

  ZinkovaABrynychovaISvacinaAJirkovskaMKorabecnaM. Cell-free DNA from human plasma and serum differs in content of telomeric sequences and its ability to promote immune response. Sci. Rep. (2017) 7:2591. 10.1038/s41598-017-02905-8

  • CrossRef
  • Google Scholar

• 88.

  XuJZhangXPelayoRMonestierMAmmolloCTSemeraroFet al. Extracellular histones are major mediators of death in sepsis. Nat Med. (2009) 15:1318–21. 10.1038/nm.2053

  • CrossRef
  • Google Scholar

• 89.

  Perez-CremadesDBueno-BetiCGarcia-GimenezJLIbanez-CabellosJSHermenegildoCPallardoFVet al. Extracellular histones disarrange vasoactive mediators release through a COX-NOS interaction in human endothelial cells. J Cell Mol Med. (2017) 21:1584–92. 10.1111/jcmm.13088

  • CrossRef
  • Google Scholar

• 90.

  AllamRDarisipudiMNTschoppJAndersHJ. Histones trigger sterile inflammation by activating the NLRP3 inflammasome. Er J. Immunol. (2013) 43:3336–42. 10.1002/eji.201243224

  • CrossRef
  • Google Scholar

• 91.

  AllamRScherbaumCRDarisipudiMNMulaySRHageleHLichtnekertJet al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol. (2012) 23:1375–88. 10.1681/ASN.2011111077

  • CrossRef
  • Google Scholar

• 92.

  YildizCPalaniyarNOtulakowskiGKhanMAPostMKueblerWMet al. Mechanical ventilation induces neutrophil extracellular trap formation. Anesthesiology (2015) 122:864–75. 10.1097/ALN.0000000000000605

  • CrossRef
  • Google Scholar

• 93.

  RubioFCooleyJAccursoFJRemold-O'donnellE. Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease. Thorax (2004) 59:318–23. 10.1136/thx.2003.014902

  • CrossRef
  • Google Scholar

• 94.

  CooleyJMcDonaldBAccursoFJCrouchECRemold-O'donnellE. Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease. J Leukoc Biol. (2008) 83:946–55. 10.1189/jlb.1007684

  • CrossRef
  • Google Scholar

• 95.

  PetersonMWWalterMENygaardSD. Effect of neutrophil mediators on epithelial permeability. Am J Respir Cell Mol Biol. (1995) 13:719–27. 10.1165/ajrcmb.13.6.7576710

  • CrossRef
  • Google Scholar

• 96.

  LeeKHCavanaughLLeungHYanFAhmadiZChongBHet al. Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis. Int J Lab Hematol. (2018) 40:392–9. 10.1111/ijlh.12800

  • CrossRef
  • Google Scholar

• 97.

  KnightJSZhaoWLuoWSubramanianVO'dellAAYalavarthiSet al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest. (2013) 123:2981–93. 10.1172/JCI67390

  • CrossRef
  • Google Scholar

• 98.

  KnightJSSubramanianVO'dellAAYalavarthiSZhaoWSmithCKet al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis. (2015) 74:2199–206. 10.1136/annrheumdis-2014-205365

  • CrossRef
  • Google Scholar

• 99.

  MartinodKFuchsTAZitomerskyNLWongSLDemersMGallantMet al. PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock. Blood (2015) 125:1948–56. 10.1182/blood-2014-07-587709

  • CrossRef
  • Google Scholar

• 100.

  BironBMChungCSChenYWilsonZFallonEAReichnerJSet al. PAD4 deficiency leads to decreased organ dysfunction and improved survival in a dual insult model of hemorrhagic shock and sepsis. J Immunol. (2018) 200:1817–28. 10.4049/jimmunol.1700639

  • CrossRef
  • Google Scholar

• 101.

  LiYLiuZLiuBZhaoTChongWWangYet al. Citrullinated histone H3: a novel target for the treatment of sepsis. Surgery (2014) 156:229–34. 10.1016/j.surg.2014.04.009

  • CrossRef
  • Google Scholar

• 102.

  WildhagenKCGarciaDe Frutos PReutelingspergerCPSchrijverRAresteCOrtega-GomezAet al. Nonanticoagulant heparin prevents histone-mediated cytotoxicity in vitro and improves survival in sepsis. Blood (2014) 123:1098–101. 10.1182/blood-2013-07-514984

  • CrossRef
  • Google Scholar

• 103.

  Marti-CarvajalAJSolaILathyrisDCardonaAF. Human recombinant activated protein C for severe sepsis. Cochr Database Syst Rev. (2012) CD004388. 10.1002/14651858.CD004388

  • CrossRef
  • Google Scholar

• 104.

  LiRHLNguyenNTablinF. Dog platelets express functional TLR4: platelet agonists upregulate platelet surface TLR4 and facilitate LPS-induced platelet activation in dogs (abstract). J Vet Emerg Crit Care (2017) 26, S1–S15. 10.1111/vec.12645

  • CrossRef
  • Google Scholar

• 105.

  NocellaCCarnevaleRBartimocciaSNovoMCangemiRPastoriDet al. Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production. Thromb Haemost. (2017) 117:1558–70. 10.1160/TH16-11-0857

  • CrossRef
  • Google Scholar

• 106.

  EisenDPReidDMcBrydeES. Acetyl salicylic acid usage and mortality in critically ill patients with the systemic inflammatory response syndrome and sepsis. Crit Care Med. (2012) 40:1761–7. 10.1097/CCM.0b013e318246b9df

  • CrossRef
  • Google Scholar

• 107.

  ChenWJanzDRBastaracheJAMayAKO'nealHR.JrBernardGRet al. Prehospital aspirin use is associated with reduced risk of acute respiratory distress syndrome in critically ill patients: a propensity-adjusted analysis. Crit Care Med. (2015) 43:801–7. 10.1097/CCM.0000000000000789

  • CrossRef
  • Google Scholar

• 108.

  EisenDPMooreEMLederKLockeryJMcBrydeESMcNeilJJet al. AspiriN To Inhibit SEPSIS (ANTISEPSIS) randomised controlled trial protocol. BMJ Open (2017) 7:e013636. 10.1136/bmjopen-2016-013636

  • CrossRef
  • Google Scholar